|
By: Kayla M. Jacob and Rachael Jeanfreau
It’s official. Medical marijuana has finally been rescheduled from a Schedule I to a Schedule III controlled substance. Well, sort of.
In late April 2026, the Department of Justice (“DOJ”) issued a final order immediately rescheduling certain medical marijuana products to Schedule III, including (1) FDA-approved products containing marijuana, and (2) marijuana products regulated by a state medical marijuana license. All other forms of marijuana, including recreational marijuana, have not been rescheduled. However, an expedited administrative hearing process to consider the broader rescheduling of marijuana has been set for June 29, 2026.
So what exactly does this mean for employers? Read more to find out.
|